Roche Pharma launches PHESGO for treatment of HER-2 positive breast cancer in India
Combines two proven blockbuster monoclonal antibodies: Perjeta® (pertuzumab) and Herceptin® (trastuzumab) in single vial for subcutaneous administration Is also the ...
